Form 4 for ABT Abbott Laboratories
Accepted 2021-10-27 00:00:00 ET · period of report 2021-10-27 · accession 0001415889-21-004998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-27 | 2021-10-27 | ABT | Ginascol John F | EVP | M - OptEx | $47.00 | +45.7K | 143.3K | +47% | +$2.15M |
| D | 2021-10-27 | 2021-10-27 | ABT | Ginascol John F | EVP | F - Tax | $128.13 | -29.6K | 113.7K | -21% | -$3.79M |
| D | 2021-10-27 | 2021-10-27 | ABT | Ginascol John F | EVP | M - OptEx | $0.00 | -45.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-10-27 | M | A | 45,709 | $47.00 | 143,262 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-10-27 | F | D | 29,588 | $128.13 | 113,674 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2021-10-27 | M | D | 45,709 | $0.00 | 0 | D | $47.00 · 2018-02-20 to 2025-02-19 | 45,709 Common Shares | (F1) Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |